Virtual Screening and Biological Evaluation of Natural Products as Novel VPS34 Inhibitors that Modulate Autophagy
ChemMedChem · 03.03.2025 · 20 (5)
DOI: 10.1002/cmdc.202400580 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemMedChem, online erschienen am 03.12.2024. Verfasst von Xiaowen Feng und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, Hefei, 230032, P.R. China. Hauptthemen laut MEDLINE: Computer Simulation, Biological Products, Class III Phosphatidylinositol 3-Kinases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Anhui Medical University, Special Fund for Young Talents, Inflammation and Immune Mediated Diseases Laboratory of Anhui Province.
Abstract (Originalsprache)
VPS34 is a sole member of class III phosphoinositide 3‐kinase involved in endosomal trafficking and autophagosome formation, making it an interesting target for cancer treatment. Here, we investigated 5,774 natural products using structure‐based virtual screening against human VPS34. 10 natural products identified by virtual screening were purchased and tested in VPS34 ADP‐Glo assay, yielding several potential VPS34 inhibitors. Amongst, Salvianolic acid A ( 4 ) and Ellagic acid ( 8 ) inhibited VPS34 with IC 50 values of 2.46 and 3.12 μM, respectively, more potent than the positivity control 3‐MA. Moreover, in vitro assays demonstrated that both of the compounds suppressed vesicle trafficking in cell‐based assay. Significantly, Salvianolic acid ( 4 ) effectively prevented autophagy in Hela cells induced either by starvation or Rapamycin, an mTOR inhibitor. In addition, in silico analysis was done to elucidate the binding mechanisms of the ligand in complex with VPS34. Overall, this study highlights the efficacy of structure‐based virtual screening and presents several natural products as VPS34 inhibitors that modulate autophagy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Medical University, Hefei, 230032, P.R. China.
- Department of Pharmacology, School of Basic Medical Sciences, Anhui Medical University, Hefei, 230032, P.R. China.
ORCID-Profile: Jiqing Ye
Förderung
- Anhui Medical University
- Special Fund for Young Talents
- Inflammation and Immune Mediated Diseases Laboratory of Anhui Province
- Nanjing Medical University
Zitieren
APA
Feng, X., Wu, B., Xu, H., Chen, C., & Ye, J. (2025). Virtual Screening and Biological Evaluation of Natural Products as Novel VPS34 Inhibitors that Modulate Autophagy. ChemMedChem, 20(5). https://doi.org/10.1002/cmdc.202400580
Vancouver
Feng X, Wu B, Xu H, Chen C, Ye J. Virtual Screening and Biological Evaluation of Natural Products as Novel VPS34 Inhibitors that Modulate Autophagy. ChemMedChem. 2025;20(5). doi:10.1002/cmdc.202400580
BibTeX
@article{Feng2025,
author = {Feng, Xiaowen and Wu, Baoming and Xu, Hanyang and Chen, Chu and Ye, Jiqing},
title = {Virtual Screening and Biological Evaluation of Natural Products as Novel VPS34 Inhibitors that Modulate Autophagy},
journal = {ChemMedChem},
year = {2025},
volume = {20},
number = {5},
doi = {10.1002/cmdc.202400580}
}
EUVIMED